Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.37
-0.15 (-0.61%)
Oct 15, 2025, 11:40 AM EDT - Market open
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
$788,062
Profits / Employee
$132,741
Market Cap
138.56B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
Dec 31, 2014 | 78,300 | 600 | 0.77% |
Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
Dec 31, 2001 | 90,000 | 0 | - |
Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
Dec 31, 1994 | 40,800 | 300 | 0.74% |
Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PFE News
- 4 hours ago - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 12 hours ago - Pfizer CEO says US pharma industry needs to collaborate with China - Reuters
- 1 day ago - TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial - Business Wire
- 2 days ago - Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 - Business Wire
- 3 days ago - Buy Any Of 14 IDEAL 'Safer' S&P 500 October Dividend Dogs - Seeking Alpha
- 4 days ago - Biotech Stocks Have Struggled Since 2021. Why They're Coming Back. - Barrons
- 5 days ago - Pfizer's Q3: The Catalyst For A Bullish Resurgence (Earnings Preview) - Seeking Alpha
- 5 days ago - Pfizer Declares Fourth-Quarter 2025 Dividend - Business Wire